Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|September 1, 2007
Evaluation of menstrual bleeding patterns: a new proposal for a universal guideline based on the analysis of more than 4500 bleeding diariesC Gerlinger, J Endrikat, G Kallischnigg, et al.
Climacteric : the Journal of the International Menopause Society|September 23, 2011
Recommendation for the collection and analysis of endometrial biopsies for hormone therapiesC Gerlinger, K Gude, S Alinčić-Kunz, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|August 31, 2002
A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrelJ Endrikat, H Blode, C Gerlinger, et al.
Contraception|March 16, 2000
Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical studyJ Endrikat, B Düsterberg, A Ruebig, et al.
Human Reproduction (Oxford, England)|January 22, 2010
Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trialT Strowitzki, J Marr, C Gerlinger, et al.
Climacteric : the Journal of the International Menopause Society|May 23, 2015
0.5 vs. 1.0 mg estradiol in combination with drospirenone for the treatment of hot flushesC Gerlinger, K Gude, T Schmelter, et al.
Contraception|September 6, 2001
Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 microg ethinylestradiol/100 microg levonorgestrel and 20 microg ethinylestradiol/500 microg norethisteroneJ Endrikat, R Hite, R Bannemerschult, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|February 9, 2005
Combined ethinylestradiol/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteersD Heger-Mahn, C Warlimont, T Faustmann, et al.
Atherosclerosis|October 1, 1994
Efficacy and tolerance of 200 mg micronised fenofibrate administered over a 6-month period in hyperlipidaemic patients: an open Belgian multicenter studyM Kornitzer, M Dramaix, M D Vandenbroek, et al.
Climacteric : the Journal of the International Menopause Society|March 28, 2013
One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal womenA R Genazzani, T Schmelter, M Schaefers, et al.
Pageof 4